Adverum Biotechnologies (NASDAQ:ADVM) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, Adverum Biotechnologies, Inc. is a gene therapy company. The Company discovers and develops novel ... American Banking News, 1 day ago
Equities Research Analysts Updated EPS Estimates for May, 5th (ACAD, AGQ, AIDIF, AIG, ALD, ANTO, ATVI, AXL, BA, BABA) - American Banking News - Earnings, 3 weeks ago
Research Analysts Updated EPS Estimates for March, 22nd (AAPL, ABMD, AGT, AHF, AINV, AKRX, ATY, BITA, BNK, CAA) - American Banking News, 2 months ago
LONDON (ShareCast) - (ShareCast News) - Investors will keep close tabs on the result of the Federal Reserve's next two-day policy meeting on Wednesday for any change of tone in the US central bank's policy statement. That comes as investors continue ...Yahoo! Finance UK and Ireland, 1 month ago
Investment Analysts Updated EPS Estimates for March, 15th (AAUKY, ARMH, ARRS, BBL, BHP, CRUS, DPM, ENZ, EOC, FC)
Anglo American plc (OTCMKTS:AAUKY) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. ARM Holdings plc (NASDAQ:ARMH) had its overweight rating reaffirmed by analysts at Pacific Crest. ARRIS Group ...American Banking News - Earnings, 2 months ago
on your WebpageAdd Widget >Get your members hooked!